|
US5877016A
(en)
|
1994-03-18 |
1999-03-02 |
Genentech, Inc. |
Human trk receptors and neurotrophic factor inhibitors
|
|
US5844092A
(en)
|
1994-03-18 |
1998-12-01 |
Genentech, Inc. |
Human TRK receptors and neurotrophic factor inhibitors
|
|
IL153375A0
(en)
|
2000-06-22 |
2003-07-06 |
Genentech Inc |
Agonist anti-trk-c monoclonal antibodies
|
|
ES2325440T3
(es)
|
2003-02-20 |
2009-09-04 |
Smithkline Beecham Corporation |
Compuestos de pirimidina.
|
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
|
PE20060664A1
(es)
|
2004-09-15 |
2006-08-04 |
Novartis Ag |
Amidas biciclicas como inhibidores de cinasa
|
|
DE102005003687A1
(de)
|
2005-01-26 |
2006-07-27 |
Sphingo Tec Gmbh |
Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
|
|
CA2608009A1
(en)
|
2005-05-16 |
2006-11-23 |
Astrazeneca Ab |
Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
|
|
ITRM20050290A1
(it)
|
2005-06-07 |
2006-12-08 |
Lay Line Genomics Spa |
Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato.
|
|
MY153898A
(en)
|
2005-06-22 |
2015-04-15 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
|
KR101379693B1
(ko)
|
2005-08-25 |
2014-04-10 |
크리어빌리스 쎄라퓨틱스 에스.피.에이. |
Ｋ-252ａ 및 그의 유도체의 중합체 컨쥬게이트
|
|
WO2007026720A1
(ja)
|
2005-08-31 |
2007-03-08 |
Taisho Pharmaceutical Co., Ltd. |
縮環ピラゾール誘導体
|
|
HUE028588T2
(hu)
|
2005-12-13 |
2016-12-28 |
Incyte Holdings Corp |
Heteroaril-szubsztituált pirrolo[2,3-b]piridinek és pirrolo[2,3-b]pirimidinek mint Janus-kináz inhibitorok
|
|
ZA200808966B
(en)
|
2006-03-27 |
2010-03-31 |
Nerviano Medical Sciences Srl |
Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
|
|
EP2529621B1
(en)
|
2006-09-22 |
2016-10-05 |
Pharmacyclics LLC |
Inhibitors of bruton's tyrosine kinase
|
|
WO2008079909A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Pyrrolo [2,3-b] pyridines as kinase modulators
|
|
RU2009122670A
(ru)
|
2006-12-21 |
2011-01-27 |
Плекссикон, Инк. (Us) |
Соединения и способы для модуляции киназ и показания к их применению
|
|
PE20121126A1
(es)
|
2006-12-21 |
2012-08-24 |
Plexxikon Inc |
Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa
|
|
BRPI0811516A2
(pt)
|
2007-05-04 |
2014-11-18 |
Irm Llc |
Compostos e composições como inibidores de c-kit e pdgfr cinase
|
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
|
EP2740731B1
(en)
|
2007-06-13 |
2016-03-23 |
Incyte Holdings Corporation |
Crystalline salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
|
|
JP2010533158A
(ja)
|
2007-07-09 |
2010-10-21 |
アストラゼネカ アクチボラグ |
化合物類−９４５
|
|
JP2010533729A
(ja)
|
2007-07-17 |
2010-10-28 |
プレキシコン，インコーポレーテッド |
キナーゼ調節のための化合物と方法、及びそのための適応
|
|
BRPI0814441A2
(pt)
|
2007-07-19 |
2015-07-14 |
Schering Corp |
Compostos de amida heterocíclica como inibidores de proteína cinase
|
|
EA018503B1
(ru)
|
2007-07-20 |
2013-08-30 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Замещенные производные индазола, активные как ингибиторы киназы
|
|
KR20100089851A
(ko)
|
2007-10-23 |
2010-08-12 |
노파르티스 아게 |
호흡기 질환의 치료를 위한 ｔｒｋｂ 항체의 용도
|
|
EP2215091B1
(en)
|
2007-12-04 |
2016-03-30 |
Nerviano Medical Sciences S.r.l. |
Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors
|
|
JP5420568B2
(ja)
|
2008-01-17 |
2014-02-19 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
改良された抗ＴｒｋＢ抗体
|
|
EP2254886B1
(en)
|
2008-03-28 |
2016-05-25 |
Nerviano Medical Sciences S.r.l. |
3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
US8158636B2
(en)
|
2008-05-19 |
2012-04-17 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
PE20091846A1
(es)
|
2008-05-19 |
2009-12-16 |
Plexxikon Inc |
DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
|
|
AU2009248774B2
(en)
|
2008-05-23 |
2012-05-31 |
Novartis Ag |
Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
|
|
CN104530052A
(zh)
|
2008-06-10 |
2015-04-22 |
普莱希科公司 |
用于激酶调节的5h-吡咯[2,3-b]吡嗪衍生物和其适应症
|
|
AU2009262068C1
(en)
|
2008-06-27 |
2015-07-02 |
Celgene Car Llc |
Heteroaryl compounds and uses thereof
|
|
CN102105151B
(zh)
|
2008-07-29 |
2013-12-18 |
内尔维阿诺医学科学有限公司 |
Cdk抑制剂在治疗神经胶质瘤中的应用
|
|
US8394802B2
(en)
|
2008-09-19 |
2013-03-12 |
Nerviano Medical Sciences S.R.L. |
3,4-dihydro-2H-pyrrolo[1,2-a]pyrazin-1-one derivatives for the modulation of the activity of protein kinases
|
|
SI2350075T1
(sl)
|
2008-09-22 |
2014-06-30 |
Array Biopharma, Inc. |
Substituirane imidazo (1,2b)piridazinske spojine kot Trk kinazni inhibitorji
|
|
CN102264736B
(zh)
|
2008-10-22 |
2013-08-14 |
阵列生物制药公司 |
作为TRK激酶抑制剂的取代的吡唑并[1,5-a]嘧啶化合物
|
|
US8912194B2
(en)
|
2008-11-24 |
2014-12-16 |
Nerviano Medical Sciences S.R.L. |
CDK inhibitor for the treatment of mesothelioma
|
|
JO3265B1
(ar)
|
2008-12-09 |
2018-09-16 |
Novartis Ag |
مثبطات بيريديلوكسى اندولات vegf-r2 واستخدامها لعلاج المرض
|
|
WO2010083283A2
(en)
|
2009-01-15 |
2010-07-22 |
Incyte Corporation |
Processes for preparing jak inhibitors and related intermediate compounds
|
|
WO2010111527A1
(en)
|
2009-03-26 |
2010-09-30 |
Plexxikon, Inc. |
Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
|
|
BRPI1012108B8
(pt)
|
2009-05-22 |
2021-05-25 |
Incyte Corp |
composto 3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]octa no- ou heptano-nitrila, sua composição, seus usos e processo para preparar um sal de ácido fosfórico
|
|
EP3045457B1
(en)
|
2009-06-15 |
2018-05-09 |
Nerviano Medical Sciences S.r.l. |
Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
EA021478B1
(ru)
|
2009-10-09 |
2015-06-30 |
Инсайт Корпорейшн |
ГИДРОКСИЛЬНЫЕ, КЕТО И ГЛЮКУРОНИДНЫЕ ПРОИЗВОДНЫЕ 3-(4-(7Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-1Н-ПИРАЗОЛ-1-ИЛ)-3-ЦИКЛОПЕНТИЛПРОПАННИТРИЛА
|
|
WO2011092120A1
(en)
|
2010-01-29 |
2011-08-04 |
Nerviano Medical Sciences S.R.L. |
6,7- dihydroimidazo [1,5-a] pyrazin-8 (5h) - one derivatives as protein kinase modulators
|
|
TWI510487B
(zh)
|
2010-04-21 |
2015-12-01 |
Plexxikon Inc |
用於激酶調節的化合物和方法及其適應症
|
|
BR122019024201B1
(pt)
|
2010-05-20 |
2021-08-03 |
Array Biopharma Inc |
Composto macrocíclico como inibidores de trk quinase, seu uso, e composição farmacêutica
|
|
UY33597A
(es)
|
2010-09-09 |
2012-04-30 |
Irm Llc |
Compuestos y composiciones como inhibidores de la trk
|
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
|
US8975267B2
(en)
|
2011-01-26 |
2015-03-10 |
Nerviano Medical Sciences S.R.L. |
Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
|
|
EP2668188B1
(en)
|
2011-01-26 |
2016-05-18 |
Nerviano Medical Sciences S.r.l. |
Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
|
|
PE20141360A1
(es)
|
2011-02-07 |
2014-10-13 |
Plexxikon Inc |
Compuestos y metodos para la modulacion de quinasas e indicaciones para los mismos.
|
|
US9199979B2
(en)
|
2011-02-24 |
2015-12-01 |
Nerviano Medical Sciences S.R.L. |
Thiazolylphenyl-benzenesulfonamido derivatives as kinase inhibitors
|
|
BR112013021638A2
(pt)
|
2011-02-25 |
2016-08-02 |
Irm Llc |
"compostos inibidores de trk, seu uso e composições que os compreendem"
|
|
US9284298B2
(en)
|
2011-04-11 |
2016-03-15 |
Nerviano Medical Sciences S.R.L. |
Pyrazolyl-pyrimidine derivatives as kinase inhibitors
|
|
RU2621732C2
(ru)
|
2011-04-19 |
2017-06-07 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Замещенные пиримидинилпирролы, активные в качестве ингибиторов киназы
|
|
EA023579B1
(ru)
|
2011-05-12 |
2016-06-30 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Замещенные производные индазола, активные в качестве ингибиторов киназы
|
|
NZ618795A
(en)
|
2011-05-13 |
2015-07-31 |
Array Biopharma Inc |
Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
|
|
EP2736514B1
(en)
|
2011-07-28 |
2017-10-18 |
Nerviano Medical Sciences S.r.l. |
Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors
|
|
ES2660265T3
(es)
|
2011-10-07 |
2018-03-21 |
Nerviano Medical Sciences S.R.L. |
Derivados de 3,4-dihidropirrolo[1,2-a]pirazin-1(2h)-ona 4-alquil-sustituidos como inhibidores de cinasa
|
|
WO2013050446A1
(en)
|
2011-10-07 |
2013-04-11 |
Nerviano Medical Sciences S.R.L. |
SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS
|
|
AU2012339753A1
(en)
|
2011-11-14 |
2014-06-19 |
Tesaro, Inc. |
Modulating certain tyrosine kinases
|
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
|
EP2802579B1
(en)
|
2012-01-13 |
2016-04-13 |
Bristol-Myers Squibb Company |
Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
|
|
US20130195797A1
(en)
*
|
2012-01-31 |
2013-08-01 |
Vertex Pharmaceuticals Incorporated |
High potency formulations of vx-950
|
|
ES2605388T3
(es)
|
2012-04-26 |
2017-03-14 |
Ono Pharmaceutical Co., Ltd. |
Compuesto inhibidor de Trk
|
|
NZ703124A
(en)
|
2012-05-23 |
2016-07-29 |
Nerviano Medical Sciences Srl |
Process for the preparation of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
|
|
TWI585088B
(zh)
|
2012-06-04 |
2017-06-01 |
第一三共股份有限公司 |
作爲激酶抑制劑之咪唑并［１，２－ｂ］嗒衍生物
|
|
AR091273A1
(es)
|
2012-06-08 |
2015-01-21 |
Biogen Idec Inc |
Inhibidores de pirimidinil tirosina quinasa
|
|
CA2876689C
(en)
|
2012-06-13 |
2022-04-26 |
Incyte Corporation |
Substituted tricyclic compounds as fgfr inhibitors
|
|
EP2872144A4
(en)
|
2012-07-11 |
2015-12-02 |
Nimbus Iris Inc |
IRAQ INHIBITOR AND USES THEREOF
|
|
NZ703495A
(en)
|
2012-07-11 |
2018-02-23 |
Blueprint Medicines Corp |
Inhibitors of the fibroblast growth factor receptor
|
|
CN104507923B
(zh)
|
2012-08-02 |
2018-02-09 |
内尔维阿诺医学科学有限公司 |
作为激酶抑制剂的取代的吡咯类活性剂
|
|
SMT201900344T1
(it)
|
2012-09-10 |
2019-07-11 |
Principia Biopharma Inc |
Composti di pirazolopirimidina come inibitori di chinasi
|
|
KR102194611B1
(ko)
|
2012-10-04 |
2020-12-23 |
유니버시티 오브 유타 리서치 파운데이션 |
티로신 수용체 키나아제 btk 억제제로서 치환된 n-(3-(피리미딘-4-일)페닐)아크릴아미드 유사체
|
|
EP2917214B1
(en)
|
2012-11-07 |
2019-08-28 |
Nerviano Medical Sciences S.r.l. |
Substituted pyrimidinyl and pyridinyl-pyrrolopyridinones, process for their preparation and their use as kinase inhibitors
|
|
EP2917183A1
(en)
|
2012-11-12 |
2015-09-16 |
Ignyta, Inc. |
Bendamustine derivatives and methods of using same
|
|
WO2014078325A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
WO2014078331A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(arylalkyl)-n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9828360B2
(en)
|
2012-11-13 |
2017-11-28 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
CA2891334C
(en)
|
2012-11-13 |
2021-10-19 |
Array Biopharma Inc. |
Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
|
|
WO2014078328A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
WO2014078372A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
ME02990B
(me)
|
2012-11-13 |
2018-10-20 |
Array Biopharma Inc |
Jedinjenja n-pirolidinil, n'-pirazolil- uree, tiouree, guanidina i cijanoguanidina kао inhibitori trka kinaze
|
|
US9981959B2
(en)
|
2012-11-13 |
2018-05-29 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
US9822118B2
(en)
|
2012-11-13 |
2017-11-21 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
WO2014078417A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
CN103848810A
(zh)
|
2012-11-30 |
2014-06-11 |
北京赛林泰医药技术有限公司 |
鲁顿酪氨酸激酶抑制剂
|
|
MX362181B
(es)
|
2013-02-19 |
2019-01-08 |
Ono Pharmaceutical Co |
Compuesto inhibidor de cinasa del receptor de tropomiosina (trk).
|
|
WO2014160521A1
(en)
|
2013-03-15 |
2014-10-02 |
Blueprint Medicines Corporation |
Piperazine derivatives and their use as kit modulators
|
|
US9617282B2
(en)
|
2013-03-15 |
2017-04-11 |
Biogen Ma Inc. |
Macrocyclic compounds as IRAK4 inhibitors for the treatment of inflammatory diseases
|
|
CN105431436B
(zh)
|
2013-05-14 |
2017-11-28 |
内尔维阿诺医学科学有限公司 |
吡咯并[2,3‑d]嘧啶衍生物，它们的制备方法和它们作为激酶抑制剂的用途
|
|
RU2015149937A
(ru)
|
2013-05-30 |
2017-07-06 |
Плексксикон Инк. |
Соединения для модулирования киназы и показания к их применению
|
|
AR096721A1
(es)
|
2013-06-25 |
2016-01-27 |
Bristol Myers Squibb Co |
Compuestos de tetrahidrocarbazol y carbazol carboxamida sustituidos
|
|
EP3016953A4
(en)
|
2013-07-02 |
2017-03-01 |
Pharmacyclics, LLC |
Purinone compounds as kinase inhibitors
|
|
EP3628749A1
(en)
|
2013-07-30 |
2020-04-01 |
Blueprint Medicines Corporation |
Ntrk2 fusions
|
|
WO2015017528A1
(en)
|
2013-07-30 |
2015-02-05 |
Blueprint Medicines Corporation |
Pik3c2g fusions
|
|
JP6612751B2
(ja)
|
2013-07-31 |
2019-11-27 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｂｔｋの阻害剤としてのピリジン、ピリミジン及びピラジンならびにその使用
|
|
RU2650512C2
(ru)
|
2013-09-18 |
2018-04-16 |
Бейджин Ханми Фармасьютикал Ко., Лтд. |
Соединение, ингибирующее активности киназ ВТК и/или JAK3
|
|
RU2677884C2
(ru)
|
2013-09-30 |
2019-01-22 |
Гуанчжоу Иннокэа Фарма Тек Ко., Лтд. |
Замещенные никотинимидные ингибиторы втк, их получение и применение в терапии раковых, воспалительных и аутоиммунных заболеваний
|
|
US9334263B2
(en)
|
2013-10-17 |
2016-05-10 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
|
MX365614B
(es)
|
2013-10-17 |
2019-06-07 |
Blueprint Medicines Corp |
Composiciones utiles para tratar trastornos relacionados con kit.
|
|
PT3395814T
(pt)
|
2013-10-25 |
2022-07-27 |
Blueprint Medicines Corp |
Inibidores do recetor do fator de crescimento de fibroblastos
|
|
WO2015061752A1
(en)
*
|
2013-10-25 |
2015-04-30 |
Pharmacyclics, Inc. |
Treatment using bruton's tyrosine kinase inhibitors and immunotherapy
|
|
CA2929316C
(en)
|
2013-11-08 |
2021-12-28 |
Takeda Pharmaceutical Company Limited |
Pyrazole for the treatment autoimmune disorders
|
|
AU2014360446A1
(en)
|
2013-12-05 |
2016-06-09 |
Pharmacyclics, Llc |
Inhibitors of Bruton's tyrosine kinase
|
|
HRP20181109T1
(hr)
|
2013-12-11 |
2018-11-02 |
Biogen Ma Inc. |
Spojevi biarila korisni za liječenje ljudskih bolesti u onkologiji, neurologiji i imunologiji
|
|
USRE50030E1
(en)
|
2013-12-13 |
2024-07-02 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
|
EP3079682A4
(en)
|
2013-12-13 |
2017-08-30 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
|
IL311677B2
(en)
|
2014-01-13 |
2025-06-01 |
Aurigene Oncology Ltd |
Bicyclic heterocyclyl derivatives as irak4 inhibitors
|
|
WO2015108992A1
(en)
|
2014-01-15 |
2015-07-23 |
Blueprint Medicines Corporation |
Heterobicyclic compounds and their use as fgfr4 receptor inhibitors
|
|
WO2015112806A2
(en)
|
2014-01-24 |
2015-07-30 |
Tp Therapeutics, Inc. |
Diaryl macrocycles as modulators of protein kinases
|
|
US10231965B2
(en)
|
2014-02-20 |
2019-03-19 |
Ignyta, Inc. |
Molecules for administration to ROS1 mutant cancer cells
|
|
WO2015161274A1
(en)
|
2014-04-18 |
2015-10-22 |
Blueprint Medicines Corporation |
Pik3ca fusions
|
|
US20170044621A1
(en)
|
2014-04-18 |
2017-02-16 |
Blueprint Medicines Corporation |
Met fusions
|
|
CN106459013B
(zh)
|
2014-05-15 |
2019-10-25 |
阵列生物制药公司 |
作为trka激酶抑制剂的化合物及其用途
|
|
WO2015191667A1
(en)
|
2014-06-10 |
2015-12-17 |
Blueprint Medicines Corporation |
Pkn1 fusions
|
|
EP3155131B1
(en)
|
2014-06-10 |
2020-02-12 |
Blueprint Medicines Corporation |
Raf1 fusions
|
|
WO2015193740A2
(en)
|
2014-06-17 |
2015-12-23 |
Acerta Pharma B.V. |
Therapeutic combinations of a btk inhibitor, a pi3k inhibitor and/or a jak-2 inhibitor
|
|
US10370724B2
(en)
|
2014-07-17 |
2019-08-06 |
Blueprint Medicines Corporation |
PRKC fusions
|
|
EP3169804B3
(en)
|
2014-07-17 |
2019-09-18 |
Blueprint Medicines Corporation |
Fgr fusions
|
|
WO2016011144A1
(en)
|
2014-07-17 |
2016-01-21 |
Blueprint Medicines Corporation |
Tert fusions
|
|
US9688680B2
(en)
|
2014-08-04 |
2017-06-27 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
|
US9545407B2
(en)
*
|
2014-08-07 |
2017-01-17 |
Pharmacyclics Llc |
Formulations of a bruton's tyrosine kinase inhibitor
|
|
HUE045237T2
(hu)
|
2014-08-18 |
2019-12-30 |
Ono Pharmaceutical Co |
TRK-inhibitáló vegyület savaddíciós sója
|
|
WO2016053771A1
(en)
|
2014-09-30 |
2016-04-07 |
Merck Sharp & Dohme Corp. |
Inhibitors of irak4 activity
|
|
WO2016050921A1
(en)
|
2014-10-02 |
2016-04-07 |
F. Hoffmann-La Roche Ag |
Pyrazole carboxamide compounds for use in the treament of disorders mediated by bruton's tyrosine kinase (btk)
|
|
MX393057B
(es)
|
2014-10-24 |
2025-03-24 |
Bristol Myers Squibb Co |
Compuestos de indol carboxamida útiles como inhibidores de cinasas.
|
|
CN107108555B
(zh)
|
2014-10-24 |
2020-12-01 |
百时美施贵宝公司 |
三环阻转异构体化合物
|
|
EP3218378B1
(en)
|
2014-11-14 |
2020-01-08 |
Nerviano Medical Sciences S.r.l. |
6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors
|
|
TWI746426B
(zh)
|
2014-11-16 |
2021-11-21 |
美商亞雷生物製藥股份有限公司 |
(S)-N-(5-((R)-2-(2,5-二氟苯基)-吡咯啶-1-基)-吡唑并[1,5-a]嘧啶-3-基)-3-羥基吡咯啶-1-甲醯胺硫酸氫鹽結晶型
|
|
US20170356052A1
(en)
|
2014-11-18 |
2017-12-14 |
Blueprint Medicines Corporation |
Prkacb fusions
|
|
WO2016106628A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
|
US9708324B2
(en)
|
2015-02-05 |
2017-07-18 |
Merck Patent Gmbh |
Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof
|
|
US9717745B2
(en)
|
2015-03-19 |
2017-08-01 |
Zhejiang DTRM Biopharma Co. Ltd. |
Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases
|
|
WO2016161570A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
Azacarbazole btk inhibitors
|
|
WO2016161571A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
Indazole and azaindazole btk inhibitors
|
|
DK3286181T3
(da)
|
2015-04-22 |
2021-04-06 |
Rigel Pharmaceuticals Inc |
Pyrazolforbindelser og fremgangsmåde til fremstilling og anvendelse af forbindelserne
|
|
WO2016174183A1
(en)
|
2015-04-30 |
2016-11-03 |
Bayer Pharma Aktiengesellschaft |
Combinations of inhibitors of irak4 with inhibitors of btk
|
|
WO2016187723A1
(en)
|
2015-05-27 |
2016-12-01 |
Pharmascience Inc. |
Inhibitors of the tec kinase enzyme family
|
|
EP3912979B1
(en)
|
2015-06-03 |
2026-03-25 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
|
ES2911888T3
(es)
|
2015-09-18 |
2022-05-23 |
Merck Patent Gmbh |
Compuestos de heteroarilo como inhibidores de IRAK y usos de los mismos
|
|
US20170035881A1
(en)
|
2015-10-19 |
2017-02-09 |
Acerta Pharma B.V. |
Therapeutic Combinations of an IRAK4 Inhibitor and a BTK Inhibitor
|
|
CN114605327B
(zh)
*
|
2015-12-16 |
2025-03-11 |
洛克索肿瘤学股份有限公司 |
可用作激酶抑制剂的化合物
|
|
HRP20211845T1
(hr)
|
2015-12-16 |
2022-03-04 |
Boehringer Ingelheim International Gmbh |
Derivati bipirazolila korisni za liječenje autoimunih bolesti
|
|
CH713411B1
(fr)
|
2015-12-18 |
2021-03-31 |
Service Regional Vaudois De Transfusion Sanguine |
Test de contrôle de qualité pour verifier l'exécution des traitements d'inanctivation des pathogènes et des cellules ciblées dans le sang, les produits dérivés du sang et les produits cosmétiques.
|
|
WO2017134685A2
(en)
|
2016-02-02 |
2017-08-10 |
Sun Pharma Advanced Research Company Limited |
Novel hydrazino compounds as btk inhibitors
|
|
WO2017205769A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
|
AU2017302019A1
(en)
|
2016-07-28 |
2019-02-07 |
Turning Point Therapeutics, Inc. |
Macrocycle kinase inhibitors
|
|
CA3158951A1
(en)
|
2016-08-15 |
2018-02-22 |
Purdue Research Foundation |
4-substituted aminoisoquinoline derivatives
|
|
AU2017312970B2
(en)
|
2016-08-16 |
2021-08-12 |
Merck Patent Gmbh |
2-oxo-imidazopyridines as reversible BTK inhibitors and uses thereof
|
|
CA2939286A1
(en)
|
2016-08-17 |
2018-02-17 |
Pharmascience Inc. |
Spirocyclic containing compounds and pharmaceutical uses thereof
|
|
AU2017315343A1
(en)
|
2016-08-24 |
2019-02-28 |
Arqule, Inc. |
Amino-pyrrolopyrimidinone compounds and methods of use thereof
|
|
MA46205A
(fr)
|
2016-09-08 |
2019-07-17 |
Sabila Biosciences Llc |
Composés 1,2-dithiolane utiles dans la neuroprotection, les maladies et les états auto-immuns et cancéreux
|
|
KR102686957B1
(ko)
|
2016-11-08 |
2024-07-22 |
주식회사 대웅제약 |
신규한 피롤로피리미딘 유도체 및 이를 포함하는 약학적 조성물
|
|
JOP20190113A1
(ar)
|
2016-11-18 |
2019-05-15 |
Biocad Joint Stock Co |
مثبطات بروتون تيروزين كيناز
|
|
CN108101905A
(zh)
|
2016-11-24 |
2018-06-01 |
中国科学院上海药物研究所 |
嘧啶并[5,4-b]吲嗪或嘧啶并[5,4-b]吡呤化合物、其制备方法及用途
|
|
WO2018103060A1
(en)
|
2016-12-09 |
2018-06-14 |
Janssen Pharmaceutica Nv |
Inhibitors of bruton's tyrosine kinase and methods of their use
|
|
CN106831789A
(zh)
|
2016-12-21 |
2017-06-13 |
南京亘泰医药技术有限公司 |
布鲁顿酪氨酸激酶抑制剂
|
|
UY37559A
(es)
|
2017-01-06 |
2018-05-31 |
Pharmacyclics Llc |
Pirazolo[3,4-b]piridina y pirrolo[2,3-b]piridina como inhibidores de la tirosina quinasa de bruton
|
|
WO2018195450A1
(en)
|
2017-04-21 |
2018-10-25 |
Epizyme, Inc. |
Combination therapies with ehmt2 inhibitors
|
|
KR20220100992A
(ko)
|
2019-12-06 |
2022-07-18 |
록쏘 온콜로지, 인코포레이티드 |
브루톤 티로신 키나제 억제제의 투여
|
|
TW202317099A
(zh)
|
2020-09-10 |
2023-05-01 |
美商絡速藥業公司 |
用於製備(s)-5-胺基-3-(4-((5-氟-2-甲氧基苯甲醯胺基)甲基)苯基)-1-(1,1,1-三氟丙烷-2-基)-1h-吡唑-4-甲醯胺之方法及中間體
|